Active hepatitis B virus vaccination in the prevention of viral reactivation in liver transplantation recipients with previous hepatitis B infection: a cohort study
BACKGROUND AND AIM OF THE STUDY: For many years, the standard treatment following liver transplantation for hepatitis B has been a combination of hepatitis B immunoglobulin and nucleos(t)ide analogues such as entecavir and tenofovir. However, because of the high costs and logistical challenges of l...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2025-05-01
|
Series: | Swiss Medical Weekly |
Online Access: | https://smw.ch/index.php/smw/article/view/4116 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|